NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/04/2025
Back to search
Official data from USPTO
JCR PHARMACEUTICALS CO., LTD.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
JCR PHARMACEUTICALS CO., LTD.
ST13
US500000079259466Class
1, 5, 10
Filing
79259466
Registration
6031505
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
07/05/2025
Trademark type
Word
Nice classes
1, 5, 10
Filing date
02/21/2019
Registration date
04/14/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/14/2020
Last transaction
07/05/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
LEASER, ANDREW
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
JCR PHARMACEUTICALS CO., LTD.
Representatives
Sandra Epp Ryan Hamre, Schumann, Mueller & Larson, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science
Class 5
Pharmaceutical preparations for humans and animalsagents affecting central nervous systemperipheral nervous systemcardiovascular systemendocrine systemexcretory systemdigestive systemrespiratory systemlymphatic systemintegumentary systemmuscular systemreproductive systemrespiratory systemskeletal systemimmune systemsensory organsagents for the treatment and prevention of inflammationinflammatory diseasesauto-immune diseasesmetabolic disordersdermatological disordersrenal and urological disordersgenetic disorderstumorsinfectious diseaseslysosomal diseasesgraft-versus-host disease
Class 10
Medical apparatus and instrumentsinjection devices for pharmaceuticalssyringes; artificial tympanic membranes; prosthetics and filling materials not for dental useartificial materials for use in the replacement of bones; gloves for medical purposes; electric massage apparatus for household purposes
Publications
History of USPTO decisions and trademark events.
34 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/14/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/12/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/12/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/12/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/12/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/12/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/05/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/18/2020
FIMP
FINAL DISPOSITION PROCESSED
08/18/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/14/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/28/2020
PUBO
PUBLISHED FOR OPPOSITION
01/28/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/08/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/23/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/17/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/17/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/17/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/17/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/13/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/13/2019
ALIE
ASSIGNED TO LIE
12/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2019
RFNT
REFUSAL PROCESSED BY IB
07/13/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/21/2019
RFRR
REFUSAL PROCESSED BY MPU
06/21/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/06/2019
CNRT
NON-FINAL ACTION WRITTEN
06/05/2019
MAFR
APPLICATION FILING RECEIPT MAILED
06/04/2019
DOCK
ASSIGNED TO EXAMINER
05/31/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/31/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/30/2019
Continuous trademark protection
Get notified about every new filing that threatens JCR PHARMACEUTICALS CO., LTD. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.